Antibody-labelled gold nanoparticles synthesized by laser ablation to detect SARS-CoV-2 antigen spike

Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radi...

Full description

Saved in:
Bibliographic Details
Published inADMET & DMPK Vol. 12; no. 1; pp. 193 - 208
Main Authors Sulfianti, Asri, Sopandi, Vidhia Tiara, Isnaeni, Isnaeni, Suryanggono, Jodi, Pambudi, Sabar, El Muttaqien, Sjaikhurrizal, Ningsih, Febby Nurdiya, Widayanti, Tika, Mardliyati, Etik, Annisa, Annisa
Format Journal Article Paper
LanguageEnglish
Published Croatia Međunarodna udruga fizikalnih kemičara 01.01.2024
International Association of Physical Chemists
International Association of Physical Chemists (IAPC)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.
AbstractList Background and purpose Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. Experimental approach The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. Key results The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. Conclusion In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.
Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.
Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.Background and purposeRapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study.The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.Experimental approachThe AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA.The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.Key resultsThe size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level.In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.ConclusionIn this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.
Background and purpose: Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Gold nanoparticles (AuNPs), a vital component of LFIA, can be synthesized by laser ablation technique. This intense laser radiation may result in monodisperse gold nanoclusters, which are impurity-free and demonstrate innovative biocompatible surface chemistry. In this current research, laser-ablated AuNPs are produced and coupled with an anti-spike SARS-CoV-2 monoclonal antibody (mAb) generated in our prior study. Experimental approach: The AuNPs from 30,000 shots of laser ablation exhibited a robust red color with a maximum absorbance peak at 520 nm. The performance of AuNPs-mAb conjugates as a signal reporter was then evaluated in half-stick LFIA. Key results: The size distribution of AuNPs shows a relatively monodisperse and unimodal distribution with average particle diameters of 44.77 nm and a surface potential of -38.5 mV. The purified anti-spike mAb SARS-CoV-2 yielded two protein bands, representing the mAb heavy chain at 55 kDa and its light chain at 25 kDa. The immobilization of anti-spike mAb onto the surface of AuNPs revealed that 25 g/ml of mAb at phosphate buffer pH 9 was required to stabilize the AuNPs. The functional test of this conjugate was performed using dipstick LFIA, and the result shows that the AuNPs-mAb conjugates could successfully detect commercial spike antigen of SARS-CoV-2 at 10 ng level. Conclusion: In this study, laser-ablated AuNPs were functionalized with anti-spike mAb SARS-CoV-2 and successfully used as a signal reporter in half-stick LFIA for detecting antigen spike SARS-CoV-2.
Author Isnaeni, Isnaeni
Sopandi, Vidhia Tiara
Annisa, Annisa
Pambudi, Sabar
Suryanggono, Jodi
Sulfianti, Asri
El Muttaqien, Sjaikhurrizal
Widayanti, Tika
Ningsih, Febby Nurdiya
Mardliyati, Etik
AuthorAffiliation 3 Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN) , Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia
2 Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University , Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia
1 Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN) , LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
AuthorAffiliation_xml – name: 1 Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN) , LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– name: 3 Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN) , Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia
– name: 2 Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University , Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia
Author_xml – sequence: 1
  givenname: Asri
  surname: Sulfianti
  fullname: Sulfianti, Asri
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 2
  givenname: Vidhia Tiara
  surname: Sopandi
  fullname: Sopandi, Vidhia Tiara
  organization: Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University, Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia
– sequence: 3
  givenname: Isnaeni
  surname: Isnaeni
  fullname: Isnaeni, Isnaeni
  organization: Research Center for Photonics, National Research and Innovation Agency Republic of Indonesia (BRIN), Physic Building no 15 442, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15314, Indonesia
– sequence: 4
  givenname: Jodi
  surname: Suryanggono
  fullname: Suryanggono, Jodi
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 5
  givenname: Sabar
  surname: Pambudi
  fullname: Pambudi, Sabar
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 6
  givenname: Sjaikhurrizal
  surname: El Muttaqien
  fullname: El Muttaqien, Sjaikhurrizal
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 7
  givenname: Febby Nurdiya
  surname: Ningsih
  fullname: Ningsih, Febby Nurdiya
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 8
  givenname: Tika
  surname: Widayanti
  fullname: Widayanti, Tika
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 9
  givenname: Etik
  surname: Mardliyati
  fullname: Mardliyati, Etik
  organization: Research Center for Vaccine and Drugs, National Research and Innovation Agency Republic of Indonesia (BRIN), LAPTIAB Building no 611-612, KST BJ Habibie, Serpong, Tangerang Selatan, Banten 15310, Indonesia
– sequence: 10
  givenname: Annisa
  surname: Annisa
  fullname: Annisa, Annisa
  organization: Department of Biology, Faculty of Mathematics and Natural Sciences, Padjajaran University, Jalan Raya Bandung, Jatinangor, Sumedang, West Java 45361, Indonesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38560711$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1vEzEQhi1UREvphR-AfOSyxV57_XFCUVSgUiUkClytsT2bbLuxw9pBCr-ehQTUnGY07zvPzGhekrOUExLymrPrrrP2HcQN1uuWafuMXHAjTaM1N2dP8nNyVcoDY4xrKxizL8i5MJ1imvMLgotUB5_jvhnB4zhipKs8Rpog5S1MdQgjFlr2qa6xDL9m2e_pCAUnCn6EOuREa6YRK4ZK7xdf7ptl_t60FGbuChMt2-ERX5HnPYwFr47xknz7cPN1-am5-_zxdrm4a6Jkuja9tcAQmTIRRQum49hzZY2FTvEAkbVeBq_6CL0GGb3ogpoNRrWedQqEuCS3B27M8OC207CBae8yDO5vIU8rd7zJsd6D7o2OrVXSGm84t15rxjoZmOz9zHp_YG13foMxYKoTjCfQUyUNa7fKPx1nVkvD7UxoDoT1FODxpPNQKVPAOXWCS8XU7H97nDjlHzss1W2GEuanQMK8K04wwbmQvPtjffN0uf_sf48VvwF3iqjp
ContentType Journal Article
Paper
Copyright Copyright © 2024 by the authors.
Copyright © 2024 by the authors. 2024
Copyright_xml – notice: Copyright © 2024 by the authors.
– notice: Copyright © 2024 by the authors. 2024
DBID NPM
7X8
VP8
5PM
DOA
DOI 10.5599/admet.2079
DatabaseName PubMed
MEDLINE - Academic
Portal of Croatian Scientific and Professional Journals – HRČAK
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1848-7718
EndPage 208
ExternalDocumentID oai_doaj_org_article_0fba7f87d296498b8119b770054c04fb
PMC10974819
oai_hrcak_srce_hr_314606
38560711
Genre Journal Article
GroupedDBID ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
GROUPED_DOAJ
M~E
NPM
OK1
PGMZT
RPM
VP8
7X8
5PM
ID FETCH-LOGICAL-d407t-f99a0ee068de32a851ef16989a561cad02b4cb6fdaf7a4db35c6f16862b056a33
IEDL.DBID DOA
ISSN 1848-7718
IngestDate Wed Aug 27 01:20:41 EDT 2025
Thu Aug 21 18:35:04 EDT 2025
Tue Feb 27 04:16:25 EST 2024
Fri Jul 11 03:25:08 EDT 2025
Thu Jan 02 22:36:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Covid-19
monoclonal antibody
lateral flow immunoassay
anti-SARS-CoV-2
Language English
License Copyright © 2024 by the authors.
cc-by: openAccess
This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d407t-f99a0ee068de32a851ef16989a561cad02b4cb6fdaf7a4db35c6f16862b056a33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
314606
OpenAccessLink https://doaj.org/article/0fba7f87d296498b8119b770054c04fb
PMID 38560711
PQID 3031134156
PQPubID 23479
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_0fba7f87d296498b8119b770054c04fb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10974819
hrcak_primary_oai_hrcak_srce_hr_314606
proquest_miscellaneous_3031134156
pubmed_primary_38560711
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Croatia
PublicationPlace_xml – name: Croatia
PublicationTitle ADMET & DMPK
PublicationTitleAlternate ADMET DMPK
PublicationYear 2024
Publisher Međunarodna udruga fizikalnih kemičara
International Association of Physical Chemists
International Association of Physical Chemists (IAPC)
Publisher_xml – name: Međunarodna udruga fizikalnih kemičara
– name: International Association of Physical Chemists
– name: International Association of Physical Chemists (IAPC)
SSID ssj0001793009
Score 2.2498975
Snippet Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome Coronavirus 2...
Background and purpose Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome...
Background and purpose: Rapid detection test via lateral flow immunoassay (LFIA) is employed as an alternate method to detect Severe Acute Respiratory Syndrome...
SourceID doaj
pubmedcentral
hrcak
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 193
SubjectTerms anti-SARS-CoV-2
Covid-19
lateral flow immunoassay
monoclonal antibodies
monoclonal antibody
Original Scientific Paper
Title Antibody-labelled gold nanoparticles synthesized by laser ablation to detect SARS-CoV-2 antigen spike
URI https://www.ncbi.nlm.nih.gov/pubmed/38560711
https://www.proquest.com/docview/3031134156
https://hrcak.srce.hr/314606
https://pubmed.ncbi.nlm.nih.gov/PMC10974819
https://doaj.org/article/0fba7f87d296498b8119b770054c04fb
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQ3ywflZHQnmrVie3EOZaKqkICVbRFvUXjeEJXLUm12R7Cr2cmXuguQuLCLXIsO_Zz7GfP-I0Q70q0sXHglXPeKBswKtBYKtdqyCs0BVq-jfzpc3F8bj9euIuNUF_sE5bkgVPH7es2QNn6MrJ9sPLBZ1kVypKpRqNtG3j2pTVvYzM1na7QsCP2kPRIWVRrH-J3ZN_JyWeLayE2erls4Opv1PJPD8mNJefooXiw5oryIH3jI3EPu8difpLEpsc9eXZ3d2rYk3N5cidDPT4RHANhEfo4KgKaj-ej_NZfR9lBRxvltT-cHMaOKOCw-EGvwyiJS-NSQkgecnLVy4hsZpCnB19O1WH_VeWSsGAJTzncLK7wqTg_-nB2eKzWQRVUpL3bSrVVRWCgLnxEkwMRLmwzjiIJxKQaiDoPtglFG6EtwcZgXFNQBtr4BOJKYMwzsdP1Hb4QktZXbJypYhGMzbGC6HNAr40LufdOz8R77uj6Julm1KxkPSUQvvW6nfW_8J2J-QTTVikpZVg2SI-1odleFzPx9heONf0ibPeADvvboaZVOmPdOkd5nidcf5dmvGOFvWwm_BbiW9Vtv-kWl5MMN9vuLRGql_-jma_E_ZzoUjrceS12VstbfEN0ZxV2p5G9O51D_QQcfgNB
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibody-labelled+gold+nanoparticles+synthesized+by+laser+ablation+to+detect+SARS-CoV-2+antigen+spike&rft.jtitle=ADMET+%26+DMPK&rft.au=Sulfianti%2C+Asri&rft.au=Sopandi%2C+Vidhia+Tiara&rft.au=Isnaeni%2C+Isnaeni&rft.au=Suryanggono%2C+Jodi&rft.date=2024-01-01&rft.issn=1848-7718&rft.eissn=1848-7718&rft.volume=12&rft.issue=1&rft.spage=193&rft_id=info:doi/10.5599%2Fadmet.2079&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1848-7718&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1848-7718&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1848-7718&client=summon